---
layout: page
title: Publications
permalink: /publications/
toggle: on
rank: 4
---
\*Authors contributed equally<br>

Members of the Akiyama laboratory indicated in _italic_  

# Journal Articles

## 2019
[Signal Transducer and Activator of Transcription 3 in Keratinocytes Regulates Histaminergic Itch but Not Nonhistaminergic Itch](https://pubmed.ncbi.nlm.nih.gov/31141156/?from_term=akiyama+itch&from_sort=date&from_pos=1)
Hashimoto T, _Sakai K_, Yosipovitch G, _Akiyama T_. Acta Derm Venereol. 2019 Sep 1;99(10):901-902. 

[Why Does Stress Aggravate Itch? A Possible Role of the Amygdala](https://pubmed.ncbi.nlm.nih.gov/30991457/?from_term=akiyama+itch&from_sort=date&from_pos=2)
_Pavlenko D_, _Akiyama T_. Exp Dermatol. 2019 Dec;28(12):1439-1441.

[A Subpopulation of Amygdala Neurons Mediates the Affective Component of Itch](https://pubmed.ncbi.nlm.nih.gov/30819800/?from_term=akiyama+itch&from_sort=date&from_pos=3)
_Sanders KM_, _Sakai K_, _Henry TD_, Hashimoto T, _Akiyama T_.
J Neurosci. 2019 Apr 24;39(17):3345-3356. doi: 10.1523/JNEUROSCI.2759-18.2019.

[Disinhibition of Touch-Evoked Itch in a Mouse Model of Psoriasis](https://pubmed.ncbi.nlm.nih.gov/30571971/?from_term=akiyama+itch&from_sort=date&from_pos=4)
_Sakai K_, _Akiyama T_.
J Invest Dermatol. 2019 Jun;139(6):1407-1410. 

[Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis](https://pubmed.ncbi.nlm.nih.gov/30460374/?from_term=akiyama+itch&from_sort=date&from_pos=5)
Hashimoto T, _Sakai K_, _Sanders KM_, Yosipovitch G, _Akiyama T_.
Acta Derm Venereol. 2019 Mar 1;99(3):298-303.

## 2018
[**The Double-Hit Gene Expression Signature Defines a Clinically and Biologically Distinct Subgroup within GCB-DLBCL**](http://ascopubs.org/doi/abs/10.1200/jco.18.01583)<br>
Ennishi D\*, **Jiang A**\*, Boyle M, Collinge B, **Grande BM**, Ben-Neriah S, **Rushton C**, **Tang J**, **Thomas N**, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, Meissner B, Saberi S, Bashashati A, Villa D, Savage KJ, Sehn LH, Kridel R, Mungall AJ, Marra MA, Shah SP, Steidl C, Connors JM, Gascoyne RD, **Morin RD**\*, and **Scott DW**\*. <br>
Journal of Clinical Oncology. December 3, 2018. 

[**Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/30275490)
<br>
**Arthur SE**\*, **Jiang A**\*, **Grande BM**\*, **Alcaide M**, Cojocaru R, **Rushton CK**, Mottok A, **Hilton LK**, Lat PK, Zhao EY, Culibrk L, Ennishi D, **Jessa S**, **Chong L**, **Thomas N**, **Pararajalingam P**, Meissner B, Boyle M, **Davidson J**, **Bushell KR**, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, **Morin RD**.
<br>
Nat Commun. 2018 Oct 1;9(1):4001. doi: 10.1038/s41467-018-06354-3.

[**Novel Multiplexing Strategies for Quantification of Rare Alleles Using ddPCR.**](https://www.ncbi.nlm.nih.gov/pubmed/29717449)
<br>
**Alcaide M**, **Morin RD**.
<br>
Methods Mol Biol. 2018;1768:275-301. doi: 10.1007/978-1-4939-7778-9\_16.

[**The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.**](https://www.ncbi.nlm.nih.gov/pubmed/29295643)
<br>
Wever CM, Geoffrion D, **Grande BM**, **Yu S**, **Alcaide M**, Lemaire M, Riazalhosseini Y, HÃ©bert J, Gavino C, Vinh DC, Petrogiannis-Haliotis T, Dmitrienko S, Mann KK, **Morin RD**\*, Johnson NA\*.
<br>
Leuk Lymphoma. 2018 Sep;59(9):2159-2174. doi: 10.1080/10428194.2017.1413186. 


## 2017

[**Targeted Error-Suppressed Detection of Circulating Paternal DNA to Establish a Diagnosis of Gestational Trophoblastic Neoplasm**](http://ascopubs.org/doi/abs/10.1200/PO.17.00154)<br>
Jean-Michel Lavoie, **Miguel Alcaide**, Rosemary A. Fisher, Michael J. Seckl, **Ryan Morin**, and Anna V. Tinker<br>
JCO Precision Oncology 2017 :1, 1-6 

[**Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits.**](https://www.ncbi.nlm.nih.gov/pubmed/28874686)
<br>
**Alcaide M**, **Yu S**, **Davidson J**, **Albuquerque M**, **Bushell K**, **Fornika D**, **Arthur S**, **Grande BM**, McNamara S, Tertre MCD, Batist G, Huntsman DG, Cavallone L, Aguilar A, Basik M, Johnson NA, Deyell RJ, Rassekh SR, **Morin RD**.
<br>
Sci Rep. 2017 Sep 5;7(1):10574. doi: 10.1038/s41598-017-10269-2.

[**Investigating the Genetic Causes of Sudden Unexpected Death in Children Through Targeted Next-Generation Sequencing Analysis.**](https://www.ncbi.nlm.nih.gov/pubmed/28807990)
<br>
Dewar LJ\*, **Alcaide M**\*, **Fornika D**, **D'Amato L**, Shafaatalab S, Stevens CM, Balachandra T, Phillips SM, Sanatani S, **Morin RD**\*, Tibbits GF\*.
<br>
Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001738. doi: 10.1161/CIRCGENETICS.116.001738.

[**Kronos: a workflow assembler for genome analytics and informatics.**](https://www.ncbi.nlm.nih.gov/pubmed/28655203)
<br>
Taghiyar MJ, Rosner J, Grewal D, **Grande BM**, Aniba R, **Grewal J**, Boutros PC, **Morin RD**, Bashashati A, Shah SP.
<br>
Gigascience. 2017 Jul 1;6(7):1-10. doi: 10.1093/gigascience/gix042.

[**Enhancing knowledge discovery from cancer genomics data with Galaxy.**](https://www.ncbi.nlm.nih.gov/pubmed/28327945)
<br>
**Albuquerque MA**, **Grande BM**, **Ritch EJ**, **Pararajalingam P**, **Jessa S**, Krzywinski M, **Grewal JK**, Shah SP, Boutros PC, **Morin RD**.
<br>
Gigascience. 2017 May 1;6(5):1-13. doi: 10.1093/gigascience/gix015.


## 2016

[**Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/27440511)
<br>
**Alcaide M**, **Yu S**, **Bushell K**, **Fornika D**, Nielsen JS, Nelson BH, Mann KK, Assouline S, Johnson NA, **Morin RD**.
<br>
Clin Chem. 2016 Sep;62(9):1238-47. doi: 10.1373/clinchem.2016.255315. 

[**Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies.**](https://www.ncbi.nlm.nih.gov/pubmed/27422709)
<br>
Volik S, **Alcaide M**, **Morin RD**, Collins C.
<br>
Mol Cancer Res. 2016 Oct;14(10):898-908. 

[**Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/27166360)
<br>
Assouline SE, Nielsen TH, **Yu S**, **Alcaide M**, **Chong L**, MacDonald D, Tosikyan A, Kukreti V, Kezouh A, Petrogiannis-Haliotis T, **Albuquerque M**, **Fornika D**, **Alamouti S**, Froment R, Greenwood CM, Oros KK, Camglioglu E, Sharma A, Christodoulopoulos R, Rousseau C, Johnson N, Crump M, **Morin RD**\*, Mann KK\*.
<br>
Blood. 2016 Jul 14;128(2):185-94. doi: 10.1182/blood-2016-02-699520. 

[**Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.**](https://www.ncbi.nlm.nih.gov/pubmed/26647218)
<br>
**Morin RD**, Assouline S, **Alcaide M**, **Mohajeri A**, **Johnston RL**, **Chong L**, **Grewal J**, **Yu S**, **Fornika D**, **Bushell K**, Nielsen TH, Petrogiannis-Haliotis T, Crump M, Tosikyan A, **Grande BM**, MacDonald D, Rousseau C, Bayat M, Sesques P, Froment R, **Albuquerque M**, Monczak Y, Oros KK, Greenwood C, Riazalhosseini Y, Arseneault M, Camlioglu E, Constantin A, Pan-Hammarstrom Q, Peng R, Mann KK, Johnson NA.
<br>
Clin Cancer Res. 2016 May 1;22(9):2290-300. doi: 10.1158/1078-0432.CCR-15-2123. 


## 2015

[**Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.**](https://www.ncbi.nlm.nih.gov/pubmed/25468570)
<br>
**Bushell KR**, **Kim Y**, Chan FC, Ben-Neriah S, **Jenks A**, **Alcaide M**, **Fornika D**, **Grande BM**, **Arthur S**, Gascoyne RD, Steidl C, **Morin RD**.
<br>
Blood. 2015 Feb 5;125(6):999-1005. doi: 10.1182/blood-2014-10-602714. 

# Review Articles


# Book

# Book Chapters
